NeoGenomics
NEO
₹644.69
Share price
2.03%
Change (1 day)
-43.14%
Change (1 year)
NeoGenomics (NEO) - Total debt
Total debt on the balance sheet as of March 2025 : ₹51.64 Billion
According to NeoGenomics 's latest financial reports the company's total debt is ₹51.64 Billion. A company’s total debt is the sum of all current and non-current debts.
NeoGenomics - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | ₹51.92 B | 1.98% |
| 2023-12-31 | ₹50.92 B | 0.73% |
| 2022-12-31 | ₹50.55 B | 10.84% |
| 2021-12-31 | ₹45.61 B | 184.53% |
| 2020-12-31 | ₹16.03 B | 69.18% |
| 2019-12-31 | ₹9.47 B | 20.67% |
| 2018-12-31 | ₹7.85 B | 16.65% |
| 2017-12-31 | ₹6.73 B | -6.7% |
| 2016-12-31 | ₹7.21 B | 52.1% |
| 2015-12-31 | ₹4.74 B | 782.5% |
| 2014-12-31 | ₹0.53 B | -16.04% |
| 2013-12-31 | ₹0.64 B | -15.07% |
| 2012-12-31 | ₹0.75 B | 65.44% |
| 2011-12-31 | ₹0.45 B | 49.86% |
| 2010-12-31 | ₹0.30 B | 84.06% |
| 2009-12-31 | ₹0.16 B | 7.83% |
| 2008-12-31 | ₹0.15 B | 261.4% |
| 2007-12-31 | ₹42.38 M | 76.12% |
| 2006-12-31 | ₹24.06 M | -62.05% |
| 2005-12-31 | ₹63.41 M | |
| 2003-12-31 | ₹26.86 M | 4043.89% |
| 2002-12-31 | ₹0.64 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | ₹149.09 B | 188.71% | 🇺🇸 USA |
 Psychemedics PMD | ₹99.56 M | -99.81% | 🇺🇸 USA |
 Quest Diagnostics
DGX | ₹561.01 B | 986.34% | 🇺🇸 USA |
 LabCorp LH | ₹556.70 B | 978.01% | 🇺🇸 USA |
 Enzo Biochem ENZB | ₹0.25 B | -99.50% | 🇺🇸 USA |